Union science and technology minister Harsh Vardhan, a physician himself and former health minister, said India has made a breakthrough in developing drugs for malaria, osteoporosis and diabetes, which will be released into markets soon. These are the three major ailments Indians are facing currently.
Harsh Vardhan, former health minister, who has been moved to Science and Technology now, said that the Indian pharmaceutical industry would soon launch these “Candidate drugs” after some final touches in research and development, while speaking at the Central Drug Research Institute (CDRI), Lucknow, an arm of the Council of Scientific and Industrial Research (CSIR).
Reiterating Prime Minister Narendra Modi’s vision to make India one of the world’s leading destinations for end-to-end drug discovery and innovation by 2020, he said the CSIR labs would strive for making the country’s Swasth Swachh Bharat Mission a reality soon.
“We are developing next generation drugs, biologics, biosimilars, gene therapeutics, stem cell therapeutics, personalised medicine and multifunctional nanomedicine,” said Dr Harsh Vardhan.
Praising the research and developments efforts in CSIR labs spread over the country, he said CSIR-CDRI, Lucknow, CSIR-Indian Institute of Chemical Technology, Hyderabad and Indian Institute of Chemical Biology, Kolkata have made an impressive progress in producing drugs for kala azar, filaria, leprosy and tuberculosis, which are available at affordable price for the common man, he noted.
The upcoming “candidate drugs” for malaria, osteoporosis and diabetes were under human trials while the CSIR-CDRI is exploring new drugs on lead molecules for fracture-healing, cancers, thrombosis, malaria and hyperglycemia.
He hoped that the CSIR laboratories will produce therapeutic and preventive measures for re-surfacing tuberculosis and other drug-resistant infectious diseases.